Raykov Rosty

Director | Chief Executive Officer | Chief Executive Officer

1 company

Average

Trades Analyzed

12M Win Rate

26.1%

Avg 3M Return

+0.2%

Avg 12M Return

-12.3%

Raykov Rosty is a Director at FENNEC PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $666K based on current market prices.

Holdings by Company

FENCJan 2, 2026

Current Shares98.3K

Value$665.7K

Net Activity-323,867

Bought: 29.2KSold: 353.0K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 4, 2025	FENC Fennec Pharmaceuticals Inc.	Director	Sell	10,000	$5.25	$52,500.00	-14.1%	+67.6%	+22.3%
Mar 5, 2025	FENC Fennec Pharmaceuticals Inc.	Director	Sell	10,000	$6.79	$67,900.00	-12.7%	+16.7%	+17.5%
Feb 5, 2025	FENC Fennec Pharmaceuticals Inc.	Director	Sell	10,000	$6.66	$66,600.00	-11.6%	-11.5%	+12.8%
Jan 6, 2025	FENC Fennec Pharmaceuticals Inc.	Director	Sell	10,000	$6.08	$60,800.00	-5.4%	-14.3%	+21.4%
Dec 5, 2024	FENC Fennec Pharmaceuticals Inc.	Director	Sell	796	$6.04	$4,807.84	-1.2%	+18.0%	+32.0%
Dec 3, 2024	FENC Fennec Pharmaceuticals Inc.	Director	Sell	1,635	$6.13	$10,022.55	-2.4%	+8.7%	+21.5%
Nov 4, 2024	FENC Fennec Pharmaceuticals Inc.	Director	Sell	2,431	$4.31	$10,477.61	-3.5%	+39.8%	+72.0%
Oct 1, 2024	FENC Fennec Pharmaceuticals Inc.	Director	Sell	2,431	$4.94	$12,009.14	-3.5%	+27.8%	+99.0%
Sep 4, 2024	FENC Fennec Pharmaceuticals Inc.	Director	Sell	2,431	$5.52	$13,419.12	-3.5%	+12.1%	+65.1%
Aug 1, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	2,431	$6.26	$15,205.90	-1.3%	-28.7%	+25.0%